3Brain AG has announced a new technology based on a unique combination of microchips and AI that promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials - and to maximize their chances of success.
Read Press ReleaseThree-dimensional microscale hanging drop arrays are useful in drug discovery, regenerative medicine, stem cell research, and biotechnology.
Read Press ReleaseActiv-2 trial provides opportunity to Miami dade County residents to participate in clinical research programs for COVID-19 with the newest medications through a private public partnership
Read Press ReleaseMedical professionals report dramatic and consistent success in treating patients gravely ill with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS)
Read Press ReleaseThe expanded Access Program provides a pathway for patients to gain access to treatment with ExoFlo outside of the active Phase II research clinical trial.
Read Press ReleaseAsia Pacific dental implants market is estimated to attain a CAGR of 6.5% till 2026 on account of significant increase in the geriatric patient pool, growing disposable income in emerging economies and rising healthcare initiatives by government.
Read Press ReleaseMajor COVID-19 test kits market players include Abbott Laboratories, Qiagen, GenMark Diagnostics, Co-Diagnostics, Seegene, F. Hoffmann-La Roche, BGI, Thermo Fisher Scientific, BioFire Diagnostics, Cepheid, Mylab Discovery Solutions, Quidel Corporation, Bio-Rad Laboratories, Randox Laboratories, and SD Biosensor.
Read Press ReleaseChina craniomaxillofacial devices market is anticipated to observe 12.5% CAGR during the forecast period led by increase in number of road accidents in the region.
Read Press ReleaseMajor HLA typing for transplant market players include Abbott, Bio-Rad Laboratories, CareDx, Qiagen N.V., Thermo Fischer Scientific, F. Hoffmann-La Roche Ltd, Illumina Inc, Luminex Corporation and Immucor, Inc.
Read Press ReleaseThe sustained acoustic medicine treatment reduces the cause of pain, accelerates the healing process, delivers mechanical compression, increases deep circulation, enhances oxygen and nutrient delivery and provides daily therapy multiple hours per day. The technology is proven in over 20 clinical trials supporting the efficacy of treatment.
Read Press ReleaseHomecare settings segment size in the cardiac arrhythmia monitoring devices market is predicted to reach USD 950 million by 2026, led by growing awareness about remote patient monitoring devices in developing countries.
Read Press ReleaseTevogen Bio believes that its highly purified antigen specific T cell investigational therapy holds promise in the treatment of viral infections including COVID-19 and Influenza A
Read Press Release